Name: UMIN ID:
Unique ID issued by UMIN | UMIN000034739 |
---|---|
Receipt number | R000039346 |
Scientific Title | Standard decision of hand cream specialized in a healthcare professionals |
Date of disclosure of the study information | 2019/05/31 |
Last modified on | 2023/05/08 10:17:04 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/11/01 15:34:09 | ||
2 | Update | 2018/11/29 20:37:10 | Anticipated trial start date |
|
3 | Update | 2018/11/29 20:38:34 | Date of disclosure of the study information |
|
4 | Update | 2019/01/31 14:10:26 | Anticipated trial start date |
|
5 | Update | 2019/01/31 14:12:03 | Date of disclosure of the study information |
|
6 | Update | 2019/03/08 13:23:33 | Key exclusion criteria Key exclusion criteria |
|
7 | Update | 2019/03/08 13:34:14 | Date of disclosure of the study information |
|
8 | Update | 2019/03/08 13:34:47 | Anticipated trial start date |
|
9 | Update | 2019/03/28 11:20:51 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
10 | Update | 2019/04/03 13:13:22 | Last follow-up date |
|
11 | Update | 2019/04/25 11:33:50 | Date of disclosure of the study information |
|
12 | Update | 2020/07/21 09:14:28 | Last follow-up date |
|
13 | Update | 2021/04/23 09:29:40 | Results Date of the first journal publication of results |
|
14 | Update | 2021/04/23 09:31:41 | Date of IRB Anticipated trial start date |
|
15 | Update | 2021/04/26 09:35:45 | Key exclusion criteria |
|
16 | Update | 2022/05/27 17:24:13 | Recruitment status |
|
17 | Update | 2022/05/27 17:25:56 | Number of participants that the trial has enrolled |
|
18 | Update | 2022/11/04 17:42:19 | Baseline Characteristics Adverse events |
|
19 | Update | 2023/05/08 10:17:04 | Results Results date posted Results Delay Reason Results Delay Reason Date of the first journal publication of results Baseline Characteristics Adverse events |